Raymond James & Associates’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Raymond James & Associates’s Portfolio HTEC Stock Details HTEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,893	Closed	-$213K	–	4186
2021 Q4	$213K	Sell	4,893 -7,971	-62%	-$356K	﹤0.01%	3658
2021 Q3	$586K	Sell	12,864 -31	-0.2%	-$1.48K	﹤0.01%	2950
2021 Q2	$621K	Buy	12,895 +729	+6%	+$33.1K	﹤0.01%	2930
2021 Q1	$534K	Buy	12,166 +7,212	+146%	+$335K	﹤0.01%	2969
2020 Q4	$217K	Buy	+4,954	New	+$194K	﹤0.01%	3340

Other funds holding HTEC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return

SCM

SOL Capital Management Rockville, Maryland $206M AUM 17.87% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Raymond James & Associates's HTEC Position: Q1 2022 in Review

Raymond James & Associates sold out of ROBO Global Healthcare Technology and Innovation ETF (HTEC) in Q1 2022, closing a stake of 4,893 shares — an estimated $213K sold.

Raymond James & Associates first reported a position in HTEC in Q4 2020 and held it in 5 quarters. The position peaked at $621K in Q2 2021. 40 funds tracked by Wall St. Rank hold HTEC as of Q1 2022.

Raymond James & Associates reported no remaining ROBO Global Healthcare Technology and Innovation ETF position as of Q1 2022 after selling out during the quarter.
Raymond James & Associates sold 4,893 ROBO Global Healthcare Technology and Innovation ETF shares in Q1 2022, an estimated $213K.
Raymond James & Associates first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q4 2020 and held it in 5 quarters.
Raymond James & Associates's ROBO Global Healthcare Technology and Innovation ETF position peaked at $621K in Q2 2021.
40 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.